Wealth Enhancement Trust Services’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$59.3K Sell
4,000
-5,404
-57% -$38.7K 0.01% 432
2026
Q2
$39.1K Buy
9,404
+404
+4% +$1.54K ﹤0.01% 531
2026
Q1
$31.6K Buy
9,000
+5,000
+125% +$16K ﹤0.01% 503
2025
Q4
$10.9K Buy
+4,000
New +$9.25K ﹤0.01% 556

Other funds holding IOVA

Wealth Enhancement Trust Services's IOVA Position: Q3 2026 in Review

Wealth Enhancement Trust Services reduced its Iovance Biotherapeutics (IOVA) stake by 57% in Q3 2026, selling an estimated $38.7K and leaving 4,000 shares worth $59.3K. The position accounts for 0.01% of the portfolio, ranked #432.

Wealth Enhancement Trust Services first reported a position in IOVA in Q4 2025 and has held it in 4 quarters since. 335 funds tracked by Wall St. Rank hold IOVA as of Q3 2026.

  • Wealth Enhancement Trust Services held 4,000 shares of Iovance Biotherapeutics worth $59.3K as of Q3 2026.
  • Wealth Enhancement Trust Services sold 5,404 Iovance Biotherapeutics shares in Q3 2026, an estimated $38.7K.
  • Iovance Biotherapeutics made up 0.01% of Wealth Enhancement Trust Services's portfolio in Q3 2026, its #432 holding.
  • Wealth Enhancement Trust Services first reported a position in Iovance Biotherapeutics in Q4 2025 and has held it in 4 quarters since.
  • 335 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q3 2026, filed 7 Oct 2026.